Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 133
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, metformin, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Daw Park, South Australia, Australia
  • +40 more
Jan 24, 2017

Diabetes, Diabetes, Type 2 Trial in Canada, United States (liraglutide, rosiglitazone, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Goodyear, Arizona
  • +88 more
Jan 24, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (NovoFine® needle 6 mm, Ultra-Fine needle 12.7 mm)

Completed
  • Diabetes
  • +3 more
  • NovoFine® needle 6 mm
  • Ultra-Fine needle 12.7 mm
  • Walnut Creek, California
  • +4 more
Jan 18, 2017

Diabetes, Diabetes, Type 2 Trial in United States (biphasic insulin aspart, pioglitazone, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart
  • +2 more
  • Birmingham, Alabama
  • +72 more
Jan 10, 2017

Diabetes, Type 2 Trial in Worldwide (albiglutide + insulin glargine, insulin glargine + preprandial lispro insulin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • albiglutide + insulin glargine
  • insulin glargine + preprandial lispro insulin
  • Birmingham, Alabama
  • +209 more
Nov 21, 2016

Diabetes, Type 2 Trial in Worldwide (albiglutide, insulin glargine)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • albiglutide
  • insulin glargine
  • Alabaster, Alabama
  • +337 more
Nov 18, 2016

Diabetes, Type 2 Trial in Worldwide ( to match albiglutide, albiglutide, metformin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • placebo to match albiglutide
  • +5 more
  • Alabaster, Alabama
  • +357 more
Nov 18, 2016

Diabetes, Type 2 Trial in Worldwide (albiglutide, sitagliptin, glimepiride)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • albiglutide
  • +6 more
  • Birmingham, Alabama
  • +385 more
Nov 18, 2016

Diabetes, Type 2 Trial in Mexico, South Africa, United States (albiglutide, albiglutide uptitration, )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • albiglutide
  • +2 more
  • Alabaster, Alabama
  • +261 more
Nov 18, 2016

Diabetes, Type 2 Trial in Worldwide (albiglutide, )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • albiglutide
  • placebo
  • Alabaster, Alabama
  • +330 more
Nov 18, 2016

Diabetes, Diabetes, Type 2 Trial in Worldwide (biphasic insulin aspart, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Bregenz, Austria
  • +107 more
Jan 4, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Worldwide (biphasic insulin aspart, biphasic human insulin)

Completed
  • Diabetes
  • +2 more
  • biphasic insulin aspart
  • biphasic human insulin
  • Graz, Austria
  • +36 more
Jan 3, 2017

Diabetes, Type 2 Trial in Worldwide (Lixisenatide (AVE0010), Placebo, Pen auto-injector)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Lixisenatide (AVE0010)
  • +3 more
  • Bridgewater, New Jersey
  • +15 more
Oct 24, 2016

Diabetes, Type 2 Trial in Worldwide (Lixisenatide (AVE0010), Placebo, Pen auto-injector)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Lixisenatide (AVE0010)
  • +4 more
  • Bridgewater, New Jersey
  • +15 more
Oct 21, 2016

Diabetes, Type 2 Trial in Worldwide (Lixisenatide (AVE0010), Placebo, Pen auto-injector)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Lixisenatide (AVE0010)
  • +3 more
  • Bridgewater, New Jersey
  • +14 more
Oct 21, 2016

Diabetes, Type 2 Trial in Worldwide (Lixisenatide (AVE0010), Pen auto-injector, Exenatide)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Lixisenatide (AVE0010)
  • +4 more
  • Bridgewater, New Jersey
  • +17 more
Oct 20, 2016

Diabetes, Type 2 Trial in Worldwide (Lixisenatide (AVE0010), Placebo, Basal Insulin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Lixisenatide (AVE0010)
  • +4 more
  • Bridgewater, New Jersey
  • +14 more
Oct 14, 2016

Diabetes, Type 2 Trial in Worldwide (Rosiglitazone/metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Vienna, Austria
  • +92 more
Aug 31, 2016

Diabetes, Type 2 Trial in Berlin, Kiel, Bratislava (GK Activator (2), Ethanol)

Terminated
  • Diabetes Mellitus, Type 2
  • Berlin, Germany
  • +2 more
Aug 23, 2016

Diabetes, Type 2 Trial in Guatemala, Mexico, United States (TAK-875, Glimepiride, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +70 more
Mar 13, 2016

Diabetes, Type 2 Trial in United States (Placebo, TAK-875, Sitagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • Placebo
  • +3 more
  • Birmingham, Alabama
  • +79 more
Mar 4, 2016

Diabetes, Type 2 Trial in Worldwide (BI 10773, BI 10773 Placebo, BI 10773 / BI 1356)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • BI 10773
  • +3 more
  • Chino, California
  • +113 more
Mar 4, 2016

Diabetes, Type 2, Hypertension Trial in Worldwide (Placebo, BI 10773)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Hypertension
  • Placebo
  • BI 10773
  • Huntsville, Alabama
  • +119 more
Jan 22, 2016

Diabetes, Type 2, Hyperglycemia Trial in Worldwide (Metformin 500 mg bid, Metformin 1000 mg bid, Empagliflozin low dose qd)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Hyperglycemia
  • Metformin 500 mg bid
  • +5 more
  • Birmingham, Alabama
  • +189 more
Jan 22, 2016

Diabetes, Type 2 Trial in Berlin, Mainz, Neuss (Placebo, BI 187004)

Completed
  • Diabetes Mellitus, Type 2
  • Placebo
  • BI 187004
  • Berlin, Germany
  • +2 more
Aug 12, 2015